You are here

Novamind Inc.

Novamind Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
NM
CSE Index: 
Currency: 

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

You are here

Novamind Inc. (NM)

SEDAR Information

Company Info

Address
150 King St. West, Suite 202
Toronto, ON M5H 1J9
Canada
Phone
(647) 953 9512
Email
Contact@novamind.ca
Website
http://www.novamind.ca
Listing date
Tuesday, January 5, 2021
Transfer Agent
Marrelli Trust Company Limited
Investor Relations
Investor Relations
Email
IR@novamind.ca
Auditor
DMCL LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
43,277,163
Reserved for Issuance: 
5,715,570

Company Officers

Yaron Conforti, Chief Executive Officer
Dr. Reid Robison, Chief Medical Officer
Dr. Paul Thielking, Chief Scientific Officer
Pierre Bou-Mansour, Chief Operating Officer
Jing Peng, Chief Financial Officer and Corporate Secretary

Bulletins

08/11/2021

2021-1115 - Reinstatement – Novamind Inc. (NM)

Le 8 novembre/November 2021

Effective immediately, Novamind Inc. will be reinstated for trading.

The Company has rectified the default situation that gave rise to the suspension.

____________________________

Avec effet immédiat, Novamind Inc. sera réintégré aux fins de négociation.

La Société a rectifié la situation de défaut ayant donné lieu à la suspension.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-01-25-Jamaica-Stock-Exchange-Conference_Website.png

17th Regional Investments & Capital Markets Conference 2022

Tuesday, January 25, 2022 to Thursday, January 27, 2022